$0,0B
Global O&P market (2030 projection)
~4-5% annual growth per industry reports
Investor Relations
We're building the digital infrastructure of medical manufacturing
Orthotics and prosthetics is one of the last corners of healthcare that digitalization has reached. With its vertically integrated platform of software, hardware and materials, Clonify Labs aims to become the operating system of this transformation.
Market Opportunity
A large, growing and not-yet-digital market
The O&P market has a demographically guaranteed demand curve: aging populations, diabetes-related amputations and pediatric cases grow demand every year. Yet the production side still relies on manual labour — exactly the kind of inefficiency software transforms best.
0%
Annual growth in digital O&P workflows
3D scanning and printing adoption is accelerating
0M+
People worldwide needing prosthetics/orthotics
Access still below 10% according to WHO data
0%
Clinics still working manually with plaster
The digitalization window is just opening
* Market figures are approximate values compiled from public industry reports; detailed sources are shared in the investor deck.
Business Model
A four-layer revenue architecture that feeds itself
Hardware connects the clinic to the ecosystem, SaaS subscriptions establish recurring revenue, and every production run generates materials revenue. Each layer strengthens the sale of the others, continuously growing revenue per clinic.
Recurring revenue
SaaS Subscriptions
Module-based monthly/annual subscriptions. Clinics add modules as they grow; net revenue retention rises naturally.
Ecosystem lock-in
Hardware Sales
Scanners and 3D printers fully integrated with the platform. Hardware acts as the entry point to the software subscription.
Consumables revenue
Material Supply
Continuous supply of certified medical resins and filaments. Every production run generates recurring consumables revenue.
Transaction revenue
Manufacturing-as-a-Service
Per-order production through partner manufacturing centers for clinics without their own printers.
So Far
A working product, not a vision
Clonify is not an idea-stage startup: four modules are live in real clinics, on real patient cases. Investment will accelerate the commercialization and scaling of a proven product.
- 4 active modules validated in the field
- Tested on real patient cases in pilot clinics
- Technology startup based at Ankara Cyberpark
- Software + hardware + materials vertical integration
Roadmap
Scaling plan
2022
Founding
Clonify Labs was founded at Ankara Cyberpark with a vision of digital transformation in O&P.
2023
First clinical validation
The cranial helmet module was successfully tested on real patient cases in pilot clinics.
2024
Ecosystem launch
Insole, AFO and prosthetic socket modules went live; hardware and materials layers were added.
2025-2026
Commercialization and scale
Growing the clinic network across Turkey, launching the scoliosis module and building the production partner network.
2027+
Regional expansion
Expansion into MENA and European markets with multilingual, regulation-compliant versions of the platform.
Be part of this transformation
Contact us for the detailed investor deck, financial projections and clinical validation data.
muammer@clonifylabs.com